Gallbladder cancer epidemiology and demographics

Jump to navigation Jump to search

Gallbladder cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Gallbladder cancer from other Diseases

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT

MRI

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Palliative Treatment

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gallbladder cancer epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gallbladder cancer epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gallbladder cancer epidemiology and demographics

CDC on Gallbladder cancer epidemiology and demographics

Gallbladder cancer epidemiology and demographics in the news

Blogs on Gallbladder cancer epidemiology and demographics

Directions to Hospitals Treating Gallbladder cancer

Risk calculators and risk factors for Gallbladder cancer epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]

Overview

Around 80 t0 95% of biliary tract cancers are gallbladder cancers. Epidemiological research has recognized striking geographic and ethnic difference. An excessive incidence in American Indians and Southeast Asia, but pretty low in the America and the arena.

Epidemiology and Demographics

Incidence

  • The countries with high incidence have high mortality rate because mortality rate relatively follows incidence.
  • American Indian and Alaska Native people had the highest gallbladder cancer incidence.

Prevalence

  • The incidence/prevalence of gallbladder cancer is approximately 21 per 100,000 cancer incidence and 75.8% gallstone prevalence in pima indian females.[1]
  • The incidence/prevalence of gallbladder cancer is approximately 7.1 per 100,000 and 64.1% in North American Indian females.[2]
  • The incidence/prevalence of gallbladder cancer is approximately 27.3 per 100,000 and 49.4% in Chilean Mapuche Indian females.[3]
  • The incidence/prevalence of gallbladder cancer is approximately 22 per 100,000 and 21.6% in East Indian females.

Case-fatality rate/Mortality rate

  • The mortality rate of gallbladder cancer is approximately 0.6%. An estimated 1,092 gallstone-related deaths for 2004 in the U.S.[4]
  • cholecystectomy carries a high mortality rate at 1% and postoperative complications of >30%.[5]
  • The mortality rate of gallbladder cnacers in chile is very high in the world.[6]

Age

  • The incidence of gallbladder cancer increases with age over 65 years
  • Gallbladder adenocarcinoma most commonly affects older persons with chronic cholecystolithiasis.

Gender

  • Females are more commonly affected by gallbladder cancer than men.The female to male gender ratio is approximately 3 to 1.[7]
  • Women with more gravidity and parity increase the risk of developing gallbladder cancer.[8]

Race

  • Gallbladder cancer usually affects individuals of  Chile, Bolivia, Ecuador, India, Pakistan, Japan, and Korea more than the rest of the world.[9]

References

  1. Sampliner RE, Bennett PH, Comess LJ, Rose FA, Burch TA (1970). "Gallbladder disease in pima indians. Demonstration of high prevalence and early onset by cholecystography". N Engl J Med. 283 (25): 1358–64. doi:10.1056/NEJM197012172832502. PMID 5481754.
  2. Miquel JF, Covarrubias C, Villaroel L, Mingrone G, Greco AV, Puglielli L, Carvallo P, Marshall G, Del Pino G, Nervi F (1998). "Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris". Gastroenterology. 115 (4): 937–46. PMID 9753497.
  3. Miquel JF, Covarrubias C, Villaroel L, Mingrone G, Greco AV, Puglielli L, Carvallo P, Marshall G, Del Pino G, Nervi F (1998). "Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris". Gastroenterology. 115 (4): 937–46. PMID 9753497.
  4. Stinton LM, Shaffer EA (2012). "Epidemiology of gallbladder disease: cholelithiasis and cancer". Gut Liver. 6 (2): 172–87. doi:10.5009/gnl.2012.6.2.172. PMC 3343155. PMID 22570746.
  5. Stinton LM, Shaffer EA (2012). "Epidemiology of gallbladder disease: cholelithiasis and cancer". Gut Liver. 6 (2): 172–87. doi:10.5009/gnl.2012.6.2.172. PMC 3343155. PMID 22570746.
  6. Lazcano-Ponce EC, Miquel JF, Muñoz N, Herrero R, Ferrecio C, Wistuba II, Alonso de Ruiz P, Aristi Urista G, Nervi F (2001). "Epidemiology and molecular pathology of gallbladder cancer". CA Cancer J Clin. 51 (6): 349–64. PMID 11760569.
  7. Lazcano-Ponce EC, Miquel JF, Muñoz N, Herrero R, Ferrecio C, Wistuba II, Alonso de Ruiz P, Aristi Urista G, Nervi F (2001). "Epidemiology and molecular pathology of gallbladder cancer". CA Cancer J Clin. 51 (6): 349–64. PMID 11760569.
  8. Hundal R, Shaffer EA (2014). "Gallbladder cancer: epidemiology and outcome". Clin Epidemiol. 6: 99–109. doi:10.2147/CLEP.S37357. PMC 3952897. PMID 24634588.
  9. Strom BL, Soloway RD, Rios-Dalenz JL, Rodriguez-Martinez HA, West SL, Kinman JL, Polansky M, Berlin JA (1995). "Risk factors for gallbladder cancer. An international collaborative case-control study". Cancer. 76 (10): 1747–56. PMID 8625043.


Template:WikiDoc Sources